Fig. 1From: A retrospective paired study: efficacy and toxicity of nimotuzumab versus cisplatin concurrent with radiotherapy in nasopharyngeal carcinomaOverall survival (a) and progression-free survival (b) of patients who received h-R3/RT (N = 52) and CDDP/RT (N = 52) treatmentBack to article page